Articles & Video
Andreas Diacon, TASK Applied Science, announced as winner of Christine Pierre Lifetime Achievement Award 2019
At this year's Clinical Trials Europe, the Christine Pierre Lifetime Achievement Award 2019 was presented to Andreas Diacon, Founder, Director and & CEO at TASK Applied Science.
Life Sciences in 2020: Predictions from industry insiders
Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
Leveraging Real World Evidence for drug approval
Since the introduction of the 21st Century Cures Act real world evidence has been gaining in popularity. We look at the opportunities and challenges it presents.
Real World Evidence: Revolutionizing the Clinical Trials Environment - WHITEPAPER
Download this exclusive whitepaper exploring how Real World Evidence is revolutionizing the clinical trials environment.
How Virtual Trials and Real World Evidence are changing the CRO landscape
Dr. Raphaela Schnurbus, Clinical Solutions & Business Development Director at CRO OPIS, explores how Virtual Trials and Real World Evidence could change the clinical trials of the future.
Real-World-Evidence Mythbusting: 5 myths holding back patient-reported RWE adoption
What is holding back patient-reported Real-World-Evidence adoption in clinical trials? Bruce Hellman, CEO and Co-founder at uMotif, busts 5 myths.
How a patient and doctors worked together to form innovative non-profit OurBrainBank
Jessica Morris tells the story of how she created the non-profit OurBrainBank after being diagnosed with glioblastoma (GBM) in 2016.
How patient-centricity can be achieved in clinical trials - INDUSTRY VOICES
We asked four clinical trial professionals to give their views regarding patient-centricity within the industry and the methods by which this can be achieved.
What increased investment means for rare disease clinical trials
Dr Julie Vallortigara from Ataxia UK explores how pharma investment is tackling the challenges in the rare disease space and creating new partnership trends.
Taking an innovative approach to collecting real world evidence - Head of Clinical Development, BTG
INTERVIEW: Nermeen Varawalla, Head of Clinical Development at BTG, explores innovative approaches to generating real world evidence in clinical trials.
Why patient-centricity must be central to clinical trials - Dr Julie Vallortigara, Ataxia UK
Dr Julie Vallortigara, Research Officer at Ataxia UK, discusses the importance of patient-centricity in clinical trials and the role patients play at the charity.
Patient-centricity in Clinical Trials Report - INDUSTRY VOICES
We asked six clinical experts to give their views on our recent patient-centricity in clinical trials report.
Taking a patient-centric approach at Cancer Research UK
Dr Stephen Nabarro, Head of Clinical Operations and Data Management at Cancer Research UK discusses insights from the recent report on the state of patient-centricity in clinical trials.
INDUSTRY REPORT: Patient-centricity in Clinical Trials
Patient-centricity in Clinical Trials 2017: Download this exclusive report based on the results of one of the largest surveys of its kind.
Patient recruitment for clinical trials: 11 innovative study designs
How to improve your patient recruitment for clinical trials with traditional and innovative clinical study designs.
Patient benefits of mobile technologies in clinical trials
How are apps, mHealth and Big Data helping make trials more patient-centric?
REPORT: Technological Innovation in Clinical Trials
Following a survey in partnership with SCORR Marketing of our global database of clinical trial professionals, we can now reveal the results.
Managing trials and patient recruitment in emerging markets
With the current high cost of research conducted in the US and EU, researchers have turned to developing countries for research participants for a number of reasons.
REPORT: The 8 biggest challenges facing clinical trial professionals
We asked dozens of clinical professionals about the biggest challenges they are facing - find the results here.